REFERENCES
- Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 1998;17:175–205
- van Soest S, Westerveld A, de Jong PT, et al. Retinitis pigmentosa: defined from a molecular point of view. Surv Ophthalmol 1999;43:321–334
- RetNET: Summaries of genes and loci causing retinal disease. Available from: https://sph.uth.tmc.edu/RetNet/sum-dis.htm [last accessed 20 May 2012]
- Tanackovic G, Ransijn A, Ayuso C, et al. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet 2011;88:643–649
- Comitato A, Spampanato C, Chakarova C, et al. Mutations in splicing factor PRPF3, causing retinal degeneration, form detrimental aggregates in photoreceptor cells. Hum Mol Genet 2007;16:1699–1707
- Maita H, Kitaura H, Ariga H, Iguchi-Ariga SM. Association of PAP-1 and Prp3p, the products of causative genes of dominant retinitis pigmentosa, in the tri-snRNP complex. Exp Cell Res 2005;302:61–68
- Maita H, Kitaura H, Keen TJ, et al. PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor. Exp Cell Res 2004;300:283–296
- Waseem NH, Vaclavik V, Webster A, et al. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2007;48:1330–1334
- Chakarova CF, Hims MM, Bolz H, et al. Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum Mol Genet 2002;11:87–92
- van Lith-Verhoeven JJ, van der Velde-Visser SD, Sohocki MM, et al. Clinical characterization, linkage analysis, and PRPC8 mutation analysis of a family with autosomal dominant retinitis pigmentosa type 13 (RP13). Ophthalmic Genet 2002;23:1–12
- Grainger RJ, Beggs JD. Prp8 protein: at the heart of the spliceosome. Rna 2005;11:533–557
- Zhao C, Bellur DL, Lu S, et al. Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs. Am J Hum Genet 2009;85:617–627
- Moore AT, Fitzke F, Jay M, et al. Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol 1993;77:473–479
- Al-Maghtheh M, Vithana E, Tarttelin E, et al. Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype. Am J Hum Genet 1996;59:864–871
- al-Maghtheh M, Inglehearn CF, Keen TJ, et al. Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet 1994;3:351–354
- Xu S, Nakazawa M, Tamai M, Gal A. Autosomal dominant retinitis pigmentosa locus on chromosome 19q in a Japanese family. J Med Genet 1995;32:915–916
- Vithana E, Al-Maghtheh M, Bhattacharya SS, Inglehearn CF. RP11 is the second most common locus for dominant retinitis pigmentosa. J Med Genet 1998;35:174–175
- Inglehearn CF, Tarttelin EE, Plant C, et al. A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet 1998;35:1–5
- Berson EL, Gouras P, Gunkel RD, Myrianthopoulos NC. Dominant retinitis pigmentosa with reduced penetrance. Arch Ophthalmol 1969;81:226–234
- Audo I, Bujakowska K, Mohand-Said S, et al. Prevalence and novelty of PRPF31 mutations in French autosomal dominant rod-cone dystrophy patients and a review of published reports. BMC Med Genet 2010;11:145–154
- Rose AM, Mukhopadhyay R, Webster AR, et al. A 112 kb deletion in chromosome 19q13.42 leads to retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011;52:6597–6603
- Rio Frio T, Wade NM, Ransijn A, et al. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest 2008;118:1519–1531
- Rose AM, Shah AZ, Waseem NH, et al. Expression of PRPF31 and TFPT: regulation in health and retinal disease. Hum Mol Genet 2012;21:4126–4137
- Hoskins AA, Friedman LJ, Gallagher SS, et al. Ordered and dynamic assembly of single spliceosomes. Science 2011;331:1289–1295
- Schultz A, Nottrott S, Hartmuth K, Luhrmann R. RNA structural requirements for the association of the spliceosomal hPrp31 protein with the U4 and U4atac small nuclear ribonucleoproteins. J Biol Chem Sep 22 2006;281:28278–28286
- Deery EC, Vithana EN, Newbold RJ, et al. Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31. Hum Mol Genet 2002;11:3209–3219
- Nottrott S, Urlaub H, Luhrmann R. Hierarchical, clustered protein interactions with U4/U6 snRNA: a biochemical role for U4/U6 proteins. Embo J 2002;21:5527–5538
- Tanackovic G, Rivolta C. PRPF31 alternative splicing and expression in human retina. Ophthalmic Genet 2009;30:76–83
- Abu-Safieh L, Vithana EN, Mantel I, et al. A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease. Mol Vis 2006;12:384–388
- Rivolta C, McGee TL, Rio Frio T, et al. Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations. Hum Mutat 2006;27:644–653
- Rio Frio T, McGee TL, Wade NM, et al. A single-base substitution within an intronic repetitive element causes dominant retinitis pigmentosa with reduced penetrance. Hum Mutat 2009;30:1340–1347
- Tanackovic G, Ransijn A, Thibault P, et al. PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet 2011;20:2116–2130
- Kohn L, Bowne SJ, S Sullivan L, et al. Breakpoint characterization of a novel approximately 59 kb genomic deletion on 19q13.42 in autosomal-dominant retinitis pigmentosa with incomplete penetrance. Eur J Hum Genet 2009;17:651–655
- Evans K, al-Maghtheh M, Fitzke FW, et al. Bimodal expressivity in dominant retinitis pigmentosa genetically linked to chromosome 19q. Br J Ophthalmol 1995;79:841–846
- Taira K, Nakazawa M, Sato M. Mutation c. 1142 del G in the PRPF31 gene in a family with autosomal dominant retinitis pigmentosa (RP11) and its implications. Jpn J Ophthalmol 2007;51:45–48
- Vithana EN, Abu-Safieh L, Pelosini L, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci 2003;44:4204–4209
- Liu JY, Dai X, Sheng J, et al. Identification and functional characterization of a novel splicing mutation in RP gene PRPF31. Biochem Biophys Res Commun 2008;367:420–426
- McGee TL, Devoto M, Ott J, et al. Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. Am J Hum Genet 1997;61:1059–1066
- Rio Frio T, Civic N, Ransijn A, et al. Two trans-acting eQTLs modulate the penetrance of PRPF31 mutations. Hum Mol Genet 2008;17:3154–3165
- Venturini G, Rose AM, Shah AZ, Bhattacharya SS, Rivolta C. CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance. PLoS Genet 2012;8:e1003040